Premature vascular senescence in metabolic syndrome: Could it be prevented and reversed by a selenorganic antioxidant and peroxynitrite scavenger ebselen?
- 31 May 2007
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Therapeutic Strategies
- Vol. 4 (1), 93-99
- https://doi.org/10.1016/j.ddstr.2007.10.006
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Contribution of p16INK4aand p21CIP1pathways to induction of premature senescence of human endothelial cells: permissive role of p53American Journal of Physiology-Heart and Circulatory Physiology, 2006
- Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal diseaseAmerican Journal of Physiology-Renal Physiology, 2005
- Circulating Inflammatory Endothelial Cells Contribute to Endothelial Progenitor Cell Dysfunction in Patients with Vasculitis and Kidney InvolvementJournal of the American Society of Nephrology, 2005
- Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: Amelioration with EbselenKidney International, 2004
- Nephropathy in Zucker Diabetic Fat Rat Is Associated with Oxidative and Nitrosative StressJournal of the American Society of Nephrology, 2004
- OXIDIZED LOW‐DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTIONClinical and Experimental Pharmacology and Physiology, 2004
- Aging, Progenitor Cell Exhaustion, and AtherosclerosisCirculation, 2003
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Kinetic study of the reaction of ebselen with peroxynitriteFEBS Letters, 1996
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988